| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria, Heart | 19 | 2020 | 247 | 3.700 |
Why?
|
| Myocardium | 39 | 2024 | 4776 | 3.180 |
Why?
|
| Energy Metabolism | 33 | 2023 | 2899 | 2.960 |
Why?
|
| PPAR alpha | 20 | 2011 | 197 | 2.720 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 17 | 2017 | 871 | 2.380 |
Why?
|
| Cardiomegaly | 13 | 2023 | 620 | 1.920 |
Why?
|
| Myocytes, Cardiac | 17 | 2023 | 1637 | 1.870 |
Why?
|
| Fatty Acids | 31 | 2023 | 1809 | 1.840 |
Why?
|
| Receptors, Estrogen | 13 | 2022 | 2187 | 1.760 |
Why?
|
| Muscle, Skeletal | 21 | 2024 | 4931 | 1.730 |
Why?
|
| Heart Failure | 24 | 2023 | 10900 | 1.660 |
Why?
|
| Glucose | 27 | 2022 | 4397 | 1.550 |
Why?
|
| Transcription Factors | 43 | 2023 | 12208 | 1.490 |
Why?
|
| Trans-Activators | 14 | 2011 | 2924 | 1.340 |
Why?
|
| Heart | 16 | 2024 | 4467 | 1.280 |
Why?
|
| Ketosis | 3 | 2023 | 49 | 1.280 |
Why?
|
| Mitochondria | 19 | 2024 | 3520 | 1.240 |
Why?
|
| 3-Hydroxybutyric Acid | 7 | 2023 | 87 | 1.200 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2019 | 315 | 1.200 |
Why?
|
| Mitochondria, Muscle | 7 | 2020 | 171 | 1.190 |
Why?
|
| Ketone Bodies | 5 | 2023 | 82 | 1.060 |
Why?
|
| Ketones | 7 | 2024 | 188 | 1.020 |
Why?
|
| Heart Diseases | 8 | 2022 | 2788 | 1.000 |
Why?
|
| Cardiomyopathies | 11 | 2023 | 1912 | 0.990 |
Why?
|
| Physical Conditioning, Animal | 5 | 2017 | 362 | 0.980 |
Why?
|
| Lipid Metabolism | 6 | 2019 | 1889 | 0.960 |
Why?
|
| GATA4 Transcription Factor | 2 | 2022 | 131 | 0.840 |
Why?
|
| Muscle Cells | 2 | 2016 | 197 | 0.730 |
Why?
|
| PPAR delta | 2 | 2011 | 43 | 0.720 |
Why?
|
| Oxidation-Reduction | 16 | 2024 | 2187 | 0.710 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2020 | 133 | 0.700 |
Why?
|
| Heat-Shock Proteins | 6 | 2010 | 822 | 0.680 |
Why?
|
| Medication Reconciliation | 1 | 2020 | 151 | 0.660 |
Why?
|
| Mice | 64 | 2024 | 81183 | 0.630 |
Why?
|
| Insulin Resistance | 10 | 2019 | 3864 | 0.630 |
Why?
|
| Muscle Proteins | 5 | 2018 | 1159 | 0.620 |
Why?
|
| Animals | 91 | 2024 | 168757 | 0.620 |
Why?
|
| Gene Expression Regulation | 17 | 2022 | 12072 | 0.620 |
Why?
|
| Aspartic Acid | 1 | 2020 | 576 | 0.600 |
Why?
|
| Adenosine Triphosphate | 11 | 2022 | 2025 | 0.600 |
Why?
|
| Mice, Knockout | 27 | 2020 | 14557 | 0.590 |
Why?
|
| Drug Discovery | 2 | 2019 | 1058 | 0.590 |
Why?
|
| Drug Repositioning | 1 | 2019 | 229 | 0.580 |
Why?
|
| Ventricular Remodeling | 6 | 2019 | 1224 | 0.570 |
Why?
|
| Calcineurin | 2 | 2009 | 226 | 0.550 |
Why?
|
| Esophageal Atresia | 2 | 2016 | 201 | 0.550 |
Why?
|
| Evoked Potentials | 5 | 2023 | 1056 | 0.540 |
Why?
|
| Signal Transduction | 17 | 2020 | 23403 | 0.540 |
Why?
|
| Genome, Mitochondrial | 1 | 2015 | 71 | 0.500 |
Why?
|
| Physical Endurance | 1 | 2017 | 370 | 0.490 |
Why?
|
| Medication Errors | 1 | 2020 | 798 | 0.480 |
Why?
|
| Oxygen Consumption | 11 | 2021 | 1869 | 0.480 |
Why?
|
| Transcriptional Activation | 6 | 2011 | 1783 | 0.470 |
Why?
|
| Mitochondrial Proteins | 6 | 2023 | 996 | 0.460 |
Why?
|
| Glycogen | 2 | 2019 | 260 | 0.460 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2022 | 1736 | 0.460 |
Why?
|
| Quality Improvement | 2 | 2020 | 3749 | 0.450 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 1199 | 0.450 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 3 | 2008 | 65 | 0.450 |
Why?
|
| Muscle Fibers, Skeletal | 5 | 2019 | 555 | 0.440 |
Why?
|
| Diabetes Mellitus | 8 | 2023 | 5751 | 0.440 |
Why?
|
| Diabetic Cardiomyopathies | 2 | 2011 | 96 | 0.440 |
Why?
|
| Protein Kinases | 3 | 2015 | 1640 | 0.430 |
Why?
|
| Hemophilia B | 1 | 2012 | 81 | 0.420 |
Why?
|
| Physical Fitness | 1 | 2017 | 733 | 0.420 |
Why?
|
| Running | 1 | 2017 | 480 | 0.420 |
Why?
|
| Calcium Signaling | 3 | 2019 | 721 | 0.410 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2011 | 106 | 0.410 |
Why?
|
| Education, Medical | 1 | 2024 | 1721 | 0.400 |
Why?
|
| Diabetic Angiopathies | 3 | 2007 | 818 | 0.400 |
Why?
|
| Hip | 1 | 2012 | 257 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 24 | 2020 | 21827 | 0.390 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 1354 | 0.380 |
Why?
|
| Venous Thromboembolism | 3 | 2024 | 1671 | 0.380 |
Why?
|
| Triglycerides | 8 | 2019 | 2454 | 0.380 |
Why?
|
| Mice, Transgenic | 15 | 2017 | 9734 | 0.370 |
Why?
|
| Transcription, Genetic | 10 | 2011 | 7722 | 0.360 |
Why?
|
| Organizations, Nonprofit | 1 | 2010 | 104 | 0.350 |
Why?
|
| Cardiac Output, Low | 3 | 2020 | 195 | 0.350 |
Why?
|
| Gene Regulatory Networks | 3 | 2017 | 1708 | 0.350 |
Why?
|
| Disease Models, Animal | 15 | 2020 | 18029 | 0.350 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2016 | 1213 | 0.350 |
Why?
|
| Lipoprotein Lipase | 1 | 2010 | 126 | 0.350 |
Why?
|
| Heart Ventricles | 4 | 2020 | 3821 | 0.350 |
Why?
|
| Hemophilia A | 1 | 2012 | 351 | 0.350 |
Why?
|
| Myocardial Contraction | 3 | 2009 | 1585 | 0.330 |
Why?
|
| Biomedical Research | 2 | 2024 | 3309 | 0.330 |
Why?
|
| PPAR-beta | 1 | 2007 | 5 | 0.320 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2019 | 2915 | 0.320 |
Why?
|
| Muscular Disorders, Atrophic | 2 | 2019 | 33 | 0.310 |
Why?
|
| Academies and Institutes | 1 | 2010 | 317 | 0.310 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2004 | 1116 | 0.310 |
Why?
|
| Insulin | 5 | 2019 | 6580 | 0.310 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 565 | 0.310 |
Why?
|
| Obesity | 7 | 2023 | 12745 | 0.310 |
Why?
|
| DNA, Mitochondrial | 3 | 2015 | 817 | 0.300 |
Why?
|
| Adaptation, Physiological | 8 | 2019 | 1312 | 0.300 |
Why?
|
| Liver | 7 | 2020 | 7474 | 0.300 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2010 | 1240 | 0.290 |
Why?
|
| Estrogen Receptor alpha | 2 | 2009 | 577 | 0.290 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2020 | 476 | 0.290 |
Why?
|
| Basal Metabolism | 1 | 2008 | 168 | 0.290 |
Why?
|
| Humans | 81 | 2024 | 744343 | 0.280 |
Why?
|
| Ventricular Pressure | 1 | 2007 | 199 | 0.280 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 3617 | 0.280 |
Why?
|
| Ion Channels | 3 | 2010 | 1056 | 0.280 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2016 | 3920 | 0.270 |
Why?
|
| Cells, Cultured | 10 | 2022 | 19229 | 0.270 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2020 | 2073 | 0.270 |
Why?
|
| Physicians | 1 | 2024 | 4567 | 0.260 |
Why?
|
| Adipose Tissue, Brown | 2 | 2008 | 757 | 0.260 |
Why?
|
| Fatty Liver | 3 | 2006 | 727 | 0.260 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2019 | 783 | 0.250 |
Why?
|
| Myoblasts, Cardiac | 1 | 2004 | 23 | 0.250 |
Why?
|
| Telomere | 1 | 2011 | 910 | 0.250 |
Why?
|
| Myosin Heavy Chains | 4 | 2016 | 414 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 9 | 2023 | 5867 | 0.240 |
Why?
|
| Stroke Volume | 7 | 2023 | 5007 | 0.240 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2020 | 393 | 0.240 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2019 | 859 | 0.240 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 850 | 0.230 |
Why?
|
| Electroencephalography | 4 | 2023 | 6150 | 0.230 |
Why?
|
| Bed Rest | 2 | 2020 | 84 | 0.230 |
Why?
|
| Animals, Newborn | 5 | 2009 | 2726 | 0.230 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2023 | 94 | 0.220 |
Why?
|
| Histones | 2 | 2023 | 2599 | 0.220 |
Why?
|
| Retinoids | 1 | 2002 | 101 | 0.210 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 491 | 0.210 |
Why?
|
| Vascular Diseases | 1 | 2010 | 1161 | 0.200 |
Why?
|
| Hindlimb Suspension | 2 | 2019 | 83 | 0.200 |
Why?
|
| Male | 48 | 2022 | 350118 | 0.200 |
Why?
|
| Myofibroblasts | 2 | 2022 | 222 | 0.200 |
Why?
|
| Leucine | 1 | 2002 | 561 | 0.190 |
Why?
|
| Hydroxybutyrates | 1 | 2020 | 82 | 0.190 |
Why?
|
| Cell Line | 7 | 2019 | 15997 | 0.190 |
Why?
|
| Muscular Diseases | 1 | 2005 | 556 | 0.190 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2004 | 851 | 0.180 |
Why?
|
| Ventricular Function, Left | 4 | 2021 | 3670 | 0.180 |
Why?
|
| Pleasure | 1 | 2020 | 41 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2018 | 15519 | 0.180 |
Why?
|
| Intermediate Care Facilities | 1 | 2019 | 9 | 0.180 |
Why?
|
| Muscles | 1 | 2005 | 1614 | 0.180 |
Why?
|
| Hemoptysis | 1 | 2021 | 155 | 0.180 |
Why?
|
| Rats | 10 | 2020 | 24260 | 0.170 |
Why?
|
| Carrier Proteins | 6 | 2018 | 5021 | 0.170 |
Why?
|
| Hydroxybutyrate Dehydrogenase | 1 | 2019 | 8 | 0.170 |
Why?
|
| Acute Coronary Syndrome | 2 | 2010 | 2337 | 0.170 |
Why?
|
| Hemostasis | 1 | 2022 | 458 | 0.170 |
Why?
|
| Aging | 3 | 2018 | 8664 | 0.170 |
Why?
|
| Phenotype | 7 | 2017 | 16365 | 0.160 |
Why?
|
| Oxygen | 2 | 2008 | 4189 | 0.160 |
Why?
|
| Gene Expression Profiling | 7 | 2016 | 9438 | 0.160 |
Why?
|
| Proteolipids | 1 | 2018 | 117 | 0.160 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 3647 | 0.160 |
Why?
|
| Reactive Oxygen Species | 5 | 2022 | 2077 | 0.160 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 314 | 0.160 |
Why?
|
| Depressive Disorder, Major | 3 | 2020 | 4644 | 0.150 |
Why?
|
| Acetylation | 4 | 2023 | 1085 | 0.150 |
Why?
|
| Exercise Tolerance | 2 | 2021 | 770 | 0.150 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2018 | 182 | 0.150 |
Why?
|
| Reward | 5 | 2023 | 941 | 0.150 |
Why?
|
| Thermodynamics | 1 | 2019 | 596 | 0.150 |
Why?
|
| Retinoid X Receptors | 2 | 2010 | 93 | 0.150 |
Why?
|
| Fructose | 1 | 2019 | 288 | 0.150 |
Why?
|
| Takayasu Arteritis | 1 | 2018 | 96 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4751 | 0.150 |
Why?
|
| Pyruvic Acid | 2 | 2008 | 200 | 0.150 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2022 | 477 | 0.150 |
Why?
|
| Affective Symptoms | 1 | 2020 | 407 | 0.140 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2022 | 2016 | 0.140 |
Why?
|
| Barbiturates | 1 | 2017 | 114 | 0.140 |
Why?
|
| Antigens, CD34 | 1 | 2018 | 657 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 4554 | 0.140 |
Why?
|
| Carbamazepine | 1 | 2017 | 229 | 0.140 |
Why?
|
| Education | 1 | 2019 | 543 | 0.140 |
Why?
|
| Arrestins | 1 | 2016 | 74 | 0.140 |
Why?
|
| Research Report | 1 | 2019 | 355 | 0.140 |
Why?
|
| Diabetes Complications | 3 | 2010 | 1359 | 0.140 |
Why?
|
| Female | 34 | 2023 | 380194 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2022 | 1127 | 0.130 |
Why?
|
| Blood Component Transfusion | 1 | 2016 | 143 | 0.130 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2016 | 424 | 0.130 |
Why?
|
| Child, Preschool | 11 | 2021 | 41006 | 0.130 |
Why?
|
| Transfection | 2 | 2016 | 5892 | 0.130 |
Why?
|
| Blood Transfusion | 1 | 2022 | 1301 | 0.130 |
Why?
|
| Oxidative Phosphorylation | 2 | 2008 | 481 | 0.130 |
Why?
|
| Thioredoxins | 1 | 2016 | 213 | 0.130 |
Why?
|
| Cardiovascular System | 2 | 2019 | 832 | 0.120 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2016 | 611 | 0.120 |
Why?
|
| Cardiotonic Agents | 3 | 2020 | 535 | 0.120 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2024 | 1164 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2020 | 1990 | 0.120 |
Why?
|
| Depression | 4 | 2023 | 7766 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1114 | 0.120 |
Why?
|
| Blotting, Northern | 3 | 2005 | 1581 | 0.120 |
Why?
|
| Dogs | 1 | 2019 | 3912 | 0.120 |
Why?
|
| Proteome | 2 | 2022 | 1799 | 0.120 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 9648 | 0.120 |
Why?
|
| Palmitic Acid | 3 | 2010 | 154 | 0.120 |
Why?
|
| Dietary Supplements | 3 | 2021 | 3297 | 0.120 |
Why?
|
| Pattern Recognition, Visual | 1 | 2020 | 824 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2018 | 495 | 0.120 |
Why?
|
| Coma | 1 | 2017 | 475 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 1265 | 0.110 |
Why?
|
| Patient Admission | 1 | 2020 | 1380 | 0.110 |
Why?
|
| Behavior Therapy | 1 | 2018 | 865 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2009 | 3772 | 0.110 |
Why?
|
| Immunomodulation | 1 | 2016 | 541 | 0.110 |
Why?
|
| Echocardiography | 2 | 2021 | 5102 | 0.110 |
Why?
|
| Lactate Dehydrogenases | 1 | 2011 | 26 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2866 | 0.100 |
Why?
|
| Glycolysis | 3 | 2019 | 827 | 0.100 |
Why?
|
| Cell Respiration | 2 | 2019 | 201 | 0.100 |
Why?
|
| Homeostasis | 2 | 2016 | 3340 | 0.100 |
Why?
|
| Gene Expression | 5 | 2011 | 7799 | 0.100 |
Why?
|
| Isoproterenol | 2 | 2010 | 399 | 0.100 |
Why?
|
| Glucose Transporter Type 4 | 3 | 2007 | 250 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15540 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 5853 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2019 | 1403 | 0.100 |
Why?
|
| Exercise | 2 | 2018 | 5615 | 0.100 |
Why?
|
| Child | 12 | 2024 | 77709 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2021 | 981 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 1587 | 0.090 |
Why?
|
| Critical Illness | 2 | 2021 | 2670 | 0.090 |
Why?
|
| Carboxy-Lyases | 2 | 2019 | 90 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 1081 | 0.090 |
Why?
|
| Disease Progression | 2 | 2019 | 13284 | 0.090 |
Why?
|
| Ventricular Dysfunction | 1 | 2011 | 143 | 0.090 |
Why?
|
| Cholesterol, VLDL | 1 | 2010 | 65 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6171 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2015 | 3494 | 0.090 |
Why?
|
| Fibrosis | 3 | 2022 | 2029 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2004 | 1866 | 0.090 |
Why?
|
| Genotype | 4 | 2010 | 12951 | 0.090 |
Why?
|
| Myocardial Ischemia | 3 | 2011 | 2148 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2010 | 18111 | 0.090 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2009 | 91 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2009 | 5179 | 0.090 |
Why?
|
| Dobutamine | 1 | 2009 | 123 | 0.090 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 15165 | 0.090 |
Why?
|
| Sirtuin 3 | 2 | 2020 | 68 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2564 | 0.080 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 514 | 0.080 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 241 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 893 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 127 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 2 | 2010 | 2727 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2004 | 1730 | 0.080 |
Why?
|
| Palmitoylcarnitine | 1 | 2008 | 4 | 0.080 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 11727 | 0.080 |
Why?
|
| Threonine | 1 | 2009 | 279 | 0.080 |
Why?
|
| Biopsy | 2 | 2020 | 6756 | 0.080 |
Why?
|
| Metalloproteases | 1 | 2008 | 62 | 0.080 |
Why?
|
| Cell Nucleus | 2 | 2010 | 2969 | 0.080 |
Why?
|
| Joint Diseases | 1 | 2012 | 480 | 0.080 |
Why?
|
| Organizational Objectives | 1 | 2010 | 438 | 0.080 |
Why?
|
| DNA Replication | 1 | 2015 | 1399 | 0.080 |
Why?
|
| Phosphorylase Kinase | 1 | 2007 | 10 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 464 | 0.080 |
Why?
|
| Thermogenesis | 2 | 2018 | 435 | 0.080 |
Why?
|
| Glycogen Phosphorylase | 1 | 2007 | 16 | 0.080 |
Why?
|
| Melanoma | 2 | 2018 | 5510 | 0.080 |
Why?
|
| Lipase | 1 | 2010 | 314 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3305 | 0.080 |
Why?
|
| RNA, Messenger | 7 | 2010 | 13033 | 0.080 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 86 | 0.080 |
Why?
|
| Blotting, Southern | 1 | 2008 | 803 | 0.080 |
Why?
|
| Hydrogen Peroxide | 2 | 2019 | 731 | 0.080 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2007 | 23 | 0.080 |
Why?
|
| Adolescent | 9 | 2023 | 85781 | 0.080 |
Why?
|
| Glucose Tolerance Test | 1 | 2010 | 1150 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2009 | 8436 | 0.080 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2008 | 142 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2008 | 3760 | 0.070 |
Why?
|
| Luciferases | 1 | 2009 | 733 | 0.070 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 2645 | 0.070 |
Why?
|
| COS Cells | 1 | 2009 | 1161 | 0.070 |
Why?
|
| Genome | 2 | 2007 | 1808 | 0.070 |
Why?
|
| Organ Specificity | 3 | 2011 | 2008 | 0.070 |
Why?
|
| Lysine | 2 | 2023 | 1007 | 0.070 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2006 | 21 | 0.070 |
Why?
|
| GTP Phosphohydrolases | 2 | 2023 | 509 | 0.070 |
Why?
|
| Citric Acid Cycle | 1 | 2008 | 232 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 2948 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2008 | 346 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2008 | 534 | 0.070 |
Why?
|
| Base Sequence | 4 | 2010 | 12797 | 0.070 |
Why?
|
| Critical Care | 1 | 2019 | 2647 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 1861 | 0.070 |
Why?
|
| Jejunum | 1 | 2008 | 480 | 0.070 |
Why?
|
| Dietary Fats | 2 | 2005 | 2017 | 0.070 |
Why?
|
| Monodelphis | 1 | 2005 | 9 | 0.070 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 675 | 0.070 |
Why?
|
| Integrases | 1 | 2008 | 533 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2010 | 1539 | 0.070 |
Why?
|
| Serine | 1 | 2009 | 826 | 0.070 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2005 | 40 | 0.070 |
Why?
|
| Binding Sites | 2 | 2005 | 6114 | 0.060 |
Why?
|
| Infant | 5 | 2021 | 35136 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2010 | 852 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2010 | 725 | 0.060 |
Why?
|
| Glutamine | 1 | 2008 | 578 | 0.060 |
Why?
|
| Muscle Contraction | 2 | 2007 | 1240 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8642 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 3462 | 0.060 |
Why?
|
| RGS Proteins | 1 | 2004 | 77 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2008 | 1137 | 0.060 |
Why?
|
| Arginine | 1 | 2008 | 944 | 0.060 |
Why?
|
| Hepatocytes | 3 | 2006 | 1211 | 0.060 |
Why?
|
| Hypertension | 4 | 2008 | 8480 | 0.060 |
Why?
|
| Response Elements | 1 | 2005 | 312 | 0.060 |
Why?
|
| DNA Primers | 3 | 2005 | 2892 | 0.060 |
Why?
|
| Drug Industry | 1 | 2010 | 746 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6365 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 1338 | 0.060 |
Why?
|
| Program Development | 1 | 2010 | 1316 | 0.060 |
Why?
|
| Proteomics | 3 | 2022 | 3638 | 0.060 |
Why?
|
| Genes, Synthetic | 1 | 2004 | 90 | 0.060 |
Why?
|
| Metabolome | 2 | 2022 | 895 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 2216 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2016 | 3679 | 0.060 |
Why?
|
| Biological Transport | 1 | 2007 | 2118 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1504 | 0.060 |
Why?
|
| Acyl-CoA Dehydrogenases | 1 | 2002 | 25 | 0.050 |
Why?
|
| Locomotion | 1 | 2005 | 378 | 0.050 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2002 | 58 | 0.050 |
Why?
|
| Vertebrates | 1 | 2004 | 227 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2011 | 2499 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5535 | 0.050 |
Why?
|
| Enzymes | 1 | 2004 | 266 | 0.050 |
Why?
|
| Malonyl Coenzyme A | 1 | 2001 | 20 | 0.050 |
Why?
|
| Doxycycline | 1 | 2004 | 326 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11483 | 0.050 |
Why?
|
| Elastin | 1 | 2003 | 308 | 0.050 |
Why?
|
| Risk Factors | 6 | 2024 | 72290 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2002 | 232 | 0.050 |
Why?
|
| Age Factors | 2 | 2012 | 18370 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2010 | 3846 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2005 | 772 | 0.050 |
Why?
|
| Ceramides | 1 | 2003 | 199 | 0.050 |
Why?
|
| Insulinoma | 1 | 2002 | 124 | 0.050 |
Why?
|
| Heart Rate | 2 | 2011 | 4091 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 1026 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2005 | 2050 | 0.050 |
Why?
|
| Adult | 8 | 2022 | 214055 | 0.050 |
Why?
|
| Genetic Linkage | 2 | 2008 | 2421 | 0.050 |
Why?
|
| Valerates | 1 | 2020 | 21 | 0.050 |
Why?
|
| Carnitine O-Acetyltransferase | 1 | 2020 | 1 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2003 | 475 | 0.050 |
Why?
|
| Rats, Inbred Dahl | 1 | 2020 | 35 | 0.050 |
Why?
|
| Incidence | 2 | 2016 | 20947 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 595 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2002 | 585 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2703 | 0.050 |
Why?
|
| Models, Animal | 1 | 2007 | 2171 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2016 | 3752 | 0.050 |
Why?
|
| Delirium | 1 | 2012 | 1609 | 0.050 |
Why?
|
| Glutathione | 1 | 2003 | 589 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2021 | 25625 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 1009 | 0.050 |
Why?
|
| Receptors, Leptin | 1 | 2002 | 360 | 0.050 |
Why?
|
| Protein Binding | 2 | 2010 | 9386 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2004 | 970 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6622 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2012 | 9849 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 794 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 936 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2003 | 1308 | 0.040 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2019 | 52 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2022 | 251 | 0.040 |
Why?
|
| Cardiolipins | 1 | 2019 | 88 | 0.040 |
Why?
|
| Feedback | 1 | 2023 | 795 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2004 | 2751 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2022 | 493 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2019 | 78 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2018 | 58 | 0.040 |
Why?
|
| Exons | 1 | 2005 | 2437 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39050 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2019 | 154 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 1676 | 0.040 |
Why?
|
| Time Factors | 5 | 2010 | 40075 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2005 | 1504 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 173 | 0.040 |
Why?
|
| Logistic Models | 1 | 2012 | 13408 | 0.040 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 20 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2012 | 7729 | 0.040 |
Why?
|
| Fasting | 1 | 2003 | 1593 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 56430 | 0.040 |
Why?
|
| Middle Aged | 9 | 2020 | 213383 | 0.040 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2016 | 12 | 0.040 |
Why?
|
| Adiposity | 1 | 2007 | 1807 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 1107 | 0.040 |
Why?
|
| Decontamination | 1 | 2017 | 69 | 0.040 |
Why?
|
| Body Weight | 2 | 2005 | 4669 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 2016 | 90 | 0.040 |
Why?
|
| Myosin Type II | 1 | 2016 | 68 | 0.040 |
Why?
|
| Plasmapheresis | 1 | 2017 | 211 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2021 | 906 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2002 | 1028 | 0.030 |
Why?
|
| Aged | 6 | 2020 | 163280 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2005 | 4217 | 0.030 |
Why?
|
| Cisplatin | 1 | 2022 | 1662 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2023 | 1341 | 0.030 |
Why?
|
| Mass Screening | 1 | 2012 | 5255 | 0.030 |
Why?
|
| Brain | 2 | 2023 | 26385 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 2029 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 8301 | 0.030 |
Why?
|
| Sirtuins | 1 | 2019 | 323 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2003 | 1951 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 2018 | 393 | 0.030 |
Why?
|
| Prevalence | 1 | 2012 | 15226 | 0.030 |
Why?
|
| Calcium Channels | 1 | 2019 | 622 | 0.030 |
Why?
|
| Estrogens | 1 | 2023 | 1566 | 0.030 |
Why?
|
| Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
| NF-E2-Related Factor 1 | 2 | 2007 | 23 | 0.030 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2017 | 235 | 0.030 |
Why?
|
| Acetyl-CoA Carboxylase | 2 | 2005 | 78 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2010 | 6077 | 0.030 |
Why?
|
| Causality | 1 | 2002 | 1275 | 0.030 |
Why?
|
| Forecasting | 1 | 2004 | 2951 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2018 | 349 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 77449 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 2938 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 5686 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 2126 | 0.030 |
Why?
|
| Antioxidants | 1 | 2022 | 1663 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2018 | 747 | 0.030 |
Why?
|
| United States | 3 | 2019 | 69872 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2007 | 8554 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2004 | 4161 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2003 | 2107 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 1791 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 1701 | 0.030 |
Why?
|
| Sarcopenia | 1 | 2018 | 368 | 0.030 |
Why?
|
| Age of Onset | 1 | 2020 | 3271 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2010 | 40561 | 0.030 |
Why?
|
| Aorta | 1 | 2020 | 2061 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 2645 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1405 | 0.030 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2014 | 252 | 0.030 |
Why?
|
| Inpatients | 1 | 2024 | 2518 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 12261 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2016 | 1726 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2014 | 15295 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 3703 | 0.020 |
Why?
|
| Chromatin | 1 | 2023 | 2934 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2005 | 6256 | 0.020 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2010 | 8 | 0.020 |
Why?
|
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2010 | 10 | 0.020 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2010 | 22 | 0.020 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 2010 | 10 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 4462 | 0.020 |
Why?
|
| Models, Biological | 1 | 2007 | 9583 | 0.020 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2002 | 440 | 0.020 |
Why?
|
| Acetyl Coenzyme A | 1 | 2010 | 74 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2018 | 2504 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 393 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 11725 | 0.020 |
Why?
|
| Systole | 1 | 2011 | 958 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2020 | 53288 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3086 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2019 | 2925 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2018 | 1938 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 2043 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 557 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2024 | 4599 | 0.020 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2008 | 56 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2021 | 3313 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2017 | 1786 | 0.020 |
Why?
|
| Mutation | 2 | 2023 | 29786 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6234 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12788 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2023 | 7880 | 0.020 |
Why?
|
| Calcium | 1 | 2019 | 5756 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 472 | 0.020 |
Why?
|
| Acute Disease | 1 | 2016 | 7149 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 1526 | 0.020 |
Why?
|
| Perfusion | 1 | 2010 | 1360 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2019 | 4286 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2008 | 493 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1953 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2005 | 330 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 514 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 13989 | 0.020 |
Why?
|
| Genes | 1 | 2008 | 1893 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2004 | 448 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2010 | 3128 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1785 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5172 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2008 | 1460 | 0.010 |
Why?
|
| Potassium | 1 | 2008 | 1336 | 0.010 |
Why?
|
| Random Allocation | 1 | 2008 | 2429 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
| Nuclear Respiratory Factors | 1 | 2002 | 19 | 0.010 |
Why?
|
| GA-Binding Protein Transcription Factor | 1 | 2002 | 46 | 0.010 |
Why?
|
| Phenylephrine | 1 | 2003 | 301 | 0.010 |
Why?
|
| Clofibric Acid | 1 | 2002 | 8 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2003 | 285 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 873 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10481 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 2008 | 763 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16689 | 0.010 |
Why?
|
| Haplotypes | 1 | 2008 | 2779 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5078 | 0.010 |
Why?
|
| Catalase | 1 | 2002 | 222 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2005 | 686 | 0.010 |
Why?
|
| Epoxy Compounds | 1 | 2002 | 136 | 0.010 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2003 | 300 | 0.010 |
Why?
|
| Heterozygote | 1 | 2008 | 2804 | 0.010 |
Why?
|
| Pregnancy | 1 | 2023 | 29144 | 0.010 |
Why?
|
| Swimming | 1 | 2002 | 206 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2015 | 5985 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2004 | 936 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2008 | 3588 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2001 | 192 | 0.010 |
Why?
|
| Cardiac Output | 1 | 2003 | 854 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 2002 | 577 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9313 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2005 | 1767 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2010 | 4199 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 1144 | 0.010 |
Why?
|
| Adiponectin | 1 | 2005 | 1100 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23338 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 1623 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2003 | 759 | 0.010 |
Why?
|
| Ethanol | 1 | 2005 | 1342 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1901 | 0.010 |
Why?
|
| Arteries | 1 | 2003 | 1119 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13815 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2002 | 2031 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 1099 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9727 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 63114 | 0.010 |
Why?
|
| Sodium | 1 | 2003 | 1623 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2003 | 1504 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2003 | 1572 | 0.010 |
Why?
|
| Inflammation | 1 | 2016 | 10638 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2003 | 1814 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 2917 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 2689 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2010 | 6544 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 6473 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6314 | 0.010 |
Why?
|
| Registries | 1 | 2008 | 8089 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2002 | 3420 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2003 | 3107 | 0.010 |
Why?
|
| Hospitalization | 1 | 2008 | 10262 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 10397 | 0.010 |
Why?
|
| Kidney | 1 | 2003 | 7186 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 2002 | 21746 | 0.000 |
Why?
|